RAF1 and neoplasm: Furthermore, its action targets tumor cell proliferation through the inhibition of Raf family kinases (predominantly C-Raf rather than B-Raf) and mainly the RAS/RAF/MEK/ERK pathways, along with angiogenesis pathways via c-KIT, FLT3, and VEGFRs [13].